July 06, 2020
Recent Advance Articles
A sixth biosimilar to Humira is approved for the treatment of plaque psoriasis and PsA.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.